A-122 | Heart Failure Management With Guideline Directed Medical Therapy (Bisoprolol Vs Carvedilol) : A Randomised Prospective Study
Year: 2026
Type: conference-abstract
Abstract: Beta-blockers, including carvedilol and bisoprolol, are commonly recommended for the management of heart failure with reduced ejection fraction (HFrEF). Variations in dosing regimens and their comparative efficacy in reducing morbidity and mortality remain a subject of debate. However different doses and their relative efficacy in reducing morbidity & mortality cause are contradictory. The present study evaluated the effects of Carvedilol and Bisoprolol in different doses on Left Ventricle Ejection Fraction (LVEF), Heart Rate, Blood Pressure, Arrhyhthmias, Inflammatory markers, MACE, Hospital Admission & Mortality in patients with HFrEF along with guideline directed medical or device therapy (GDMT).
Authors: Hakim Irfan Showkat, Sadaf Anwar
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,400
OpenAlex ID: W7155386969